Learn More
R&D Systems™ Human CD8 alpha/beta Heterodimer Recombinant , Carrier-Free
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marca: R&D Systems™ 9358-CD-050
Descripción
The Recombinant Human CD8 alpha/beta Heterodimer Protein is derived from HEK293. The Recombinant Human CD8 alpha/beta Heterodimer Protein has been validated for the following applications: Bioactivity.Información de órdenes
Ships at ambient temperature.
Especificaciones
| P01732 (CD8 alpha), P10966 (CD8 beta) | |
| 925 | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Disulfide-linked heterodimer | |
| 0.8 to 4μg/mL | |
| Unconjugated |
| Lyophilized from a 0.2μm filtered solution in PBS | |
| 26 kDa | |
| Human embryonic kidney cell,HEK293-derived human CD8 protein, (N-terminus) Human CD8 alpha (Ser22-Asp182) Accession &Num; P01732 Acidic Tail HHHHHH Human CD8 beta (Asn19-Pro170) Accession &Num; P10966 Basic Tail FLAG (DYKDDDDK) (C-terminus) | |
| RUO | |
| <0.10 EU per 1μg of the protein by the LAL method | |
| Recombinant protein | |
| Yes |
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
For Research Use Only.